NHS Commended Guidelines


Please add site addresses here

Useful sites not listed here



Last Updated 26 August 2009


NHS Commended Guidelines

GASTROENTEROLOGY/DIGESTIVE SYSTEM
  • 1. Helicobacter pylori and peptic ulcer (Effectiveness Matters - September 1995 Volume 1 Issue 2)
  • 2. Laparoscopic surgery for the treatment of colorectal cancer (NICE) Technology Appraisal 105 - August 2006
  • 3. Laparoscopic surgery for inguinal hernia repair (NICE) Technology Appraisal 83 - September 2004
  • 4. Management of upper gastro-intestinal cancers (Effective Health Care - October 2000 Volume 6 Number 4)
  • 5. Dyspepsia: Managing dyspepsia in adults in primary care (NICE) Clinical guidelines CG17 - August 2004
  • 6. Effectiveness of laxatives in adults (Effective Health Care - September 2001 Volume 7 Issue 1)
  • 7. Guidance on the use of infliximab for Crohn’s disease (NICE) Technology Appraisal Guidance - No.40 - April 2002
  • 8. Antimicrobial prophylaxis in colorectal surgery (Effective Health Care - October 1998 Volume 4 Number 5)
  • 9. Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (NICE) Technology appraisal 86 - October 2004
  • 10. Stapled haemorrhoidopexy for the treatment of haemorrhoids (NICE) Technology Appraisal Guidance 128 - September 2007
  • 11. Infliximab for subacute manifestations of ulcerative colitis (NICE) Technology Appraisal Guidance 140 - April 2008
  • 12. Infliximab for acute exacerbations of ulcerative colitis (NICE) Technology Appraisal Guidance 163 - December 2008
  • CARDIOVASCULAR
  • 1. Investigation and management of stable angina: revised guidelines 1998 (Joint Working Party of the British Cardiac Society and Royal College of Physicians of London)
  • 2. Cardiac rehabilitation (Effective Health Care - October 1998 Volume 4 Number 4)
  • 3. Cholesterol and coronary heart disease: Screening and treatment(Effective Health Care - February 1998 Volume 4 Number 1)
  • 4. Management of stable angina (Effective Health Care - October 1997 Volume 3 Number 5)
  • 5. Aspirin and myocardial infarction (Effectiveness Matters - 1995 Volume 1 Issue 1)
  • 6. The primary care management of stable angina (COmputerised Guidelines Evaluation in the NorTh of England (COGENT) - 2007) Family Practice - 18 (2) pp 217 - 222 (2001)
  • 7. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction (NICE) Technology Appraisal Guidance - No.73 - November 2003
  • 8. Drug treatment of essential hypertension in older people (Effectiveness Matters - October 1999 Volume 4 Number 2)
  • 9. Guidance on on the use of coronary artery stents (NICE) Technology Appraisal 71 - October 2003
  • 10. Drug-eluting stents for the treatment of coronary artery disease (part review of NICE technology appraisal guidance 71) (NICE) Technology Appraisal 152 - July 2008
  • 11. Implantable cardioverter defibrillators for arrhythmias: Review of Technology Appraisal 11 (NICE) Technology Appraisal 95 - January 2006
  • 12. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (NICE) Technology Appraisal Guidance - No.47 - September 2002
  • 13. Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome (NICE) Technology Appraisal 80 - July 2004
  • 14. Endovascular stent–grafts for the treatment of abdominal aortic aneurysms (NICE) Technology Appraisal Guidance 167 - February 2009
  • 15. Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block (NICE) Technology Appraisal 88 - February 2005
  • 16. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease (NICE) Clinical guidelines CG67 - May 2008
  • 17. Cardiac resynchronisation therapy for the treatment of heart failure (NICE) Technology Appraisal Guidance 120 - May 2007
  • 18. Alteplase for the treatment of acute ischaemic stroke (NICE) Technology Appraisal Guidance 122 - June 2007
  • 19. Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction (NICE) Technology Appraisal Guidance - No.52 - October 2002
  • 20. Clopidogrel and modified release dipyridamole in the prevention of occlusive vascular events (NICE) Technology Appraisal 90 - May 2005
  • 21. Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults (NICE) Technology Appraisal Guidance 157 - September 2008
  • 22. Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (NICE) Technology Appraisal Guidance 170 - April 2009


  • CHD and Stroke Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))
  • Other Vascular Disease Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • INFECTION/COMMUNICABLE DISEASES
  • 1. Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C (NICE) Technology Appraisal Guidance 106 - August 2006
  • 2. Saving Lives: reducing infection, delivering clean and safe care (Department of Health - 21 June 2007)
  • 3. Drug Misuse and Dependence: Guidelines on Clinical Management (Department of Health - 15 March 1999)
  • 4. Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B (NICE) Technology Appraisal 96 - February 2006
  • 5. Entecavir for the treatment of chronic hepatitis B (NICE) Technology Appraisal Guidance 153 - August 2008
  • 6. Telbivudine for the treatment of chronic hepatitis B (NICE) Technology Appraisal Guidance 154 - August 2008
  • 7. TInterferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C (NICE) Technology Appraisal 75 - January 2004
  • 8. Drotrecogin alfa (activated) for severe sepsis (NICE) Technology appraisal 84 - September 2004
  • 9. Tenofovir disoproxil for the treatment of chronic hepatitis B (NICE) Technology Appraisal Guidance 173 - July 2009

  • RESPIRATORY
  • 1. Guidance on inhaler systems (devices) for children under the age of 5 years with chronic asthma (NICE) Technology Appraisal Guidance - No.10 - August 2000
  • 2. Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years) (NICE) Technology Appraisal Guidance - No.38 - March 2002
  • 3. Inhaler devices for the management of asthma and COPD (Effective Health Care - 2003 Volume 8 Number 1)
  • 4. Omalizumab for severe persistent allergic asthma (NICE) Technology Appraisal Guidance 133 - November 2007
  • 5. Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over (NICE) Technology Appraisal Guidance 138 - March 2008
  • 6. Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years (NICE) Technology Appraisal Guidance 131 - November 2007


  • Respiratory Medicine Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))
  • British guideline on the management of asthma Guideline No. 101 (May 2008) (Scottish Intercollegiate Guidelines Network (SIGN))

  • CENTRAL NERVOUS SYSTEM
  • 1. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease (amended) (NICE) Technology Appraisal Guidance 111 (amended) - November 2006 (amended September 2007)
  • 2. Guidance on the use of Riluzole (Rilutek) for the treatment of motor neurone disease (NICE) Technology Appraisal Guidance - No.20 - January 2001
  • 3. Beta interferon and glatiramer acetate for the treatment of multiple sclerosis (NICE) Technology Appraisal Guidance - No.32 - January 2002
  • 4. Interventions for the management of CFS/ME (Effective Health Care - 2002 Volume 7 Number 4)
  • 5. Newer drugs for epilepsy in adults (NICE) Technology appraisal 76 - March 2004
  • 6. Newer drugs for epilepsy in children (NICE) Technology appraisal 79 - April 2004
  • 7. Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis (NICE) Technology Appraisal Guidance 127 - August 2007
  • 8. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin (NICE) Technology Appraisal Guidance 159 - October 2008


  • Diagnosis and management of headache in adults Guideline No. 107 (November 2008) (Scottish Intercollegiate Guidelines Network (SIGN))
  • Early management of patients with a head injury Guideline No. 110 (May 2009) (Scottish Intercollegiate Guidelines Network (SIGN))

  • MENTAL HEALTH
  • 1. Drug treatments for Schizophrenia (Effective Health Care - December 1999 Volume 5 Number 6)
  • 2. Mental health promotion in high risk groups (Effective Health Care - June 1997 Volume 3 Number 3)
  • 3. Drug misuse and dependence - guidelines on clinical management (Department of Health - 15 March 1999)
  • 4. Psychosocial interventions for schizophrenia (Effective Health Care - August 2000 Volume 6 Number 3)
  • 5. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (NICE) Technology Appraisal 98 - March 2006
  • 6. Core interventions in the treatment and management of schizophrenia in primary and secondary care (update) (NICE) Clinical guidelines CG82 - March 2009
  • 7. Treatment choice in psychological therapies and counselling (Department of Health - 19 February 2001)
  • 8. Improving the recognition and management of depression in primary care (Effective Health Care - 2002 Volume 7 Number 5)
  • 9. Computerised cognitive behaviour therapy for depression and anxiety - Review of Technology Appraisal 51 (NICE) Technology appraisal 97 - February 2006
  • 10. Guidance on the use of electroconvulsive therapy (NICE) Technology Appraisal 59 - April 2003
  • 11. Brief interventions and alcohol use (Effective Health Care - November 1993 Number 7)
  • 12. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care (NICE) Clinical guidelines CG38 - July 2006
  • 13. Parent-training/education programmes in the management of children with conduct disorders (NICE) Technology appraisal guidance 102 - July 2006
  • 14. Methadone and buprenorphine for the management of opioid dependence (NICE) Technology appraisal guidance 114 - January 2007
  • 15. Naltrexone for the management of opioid dependence (NICE) Technology appraisal guidance 115 - January 2007
  • 16. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (NICE) Technology appraisal 77 - April 2004
  • 17. Structural neuroimaging in first-episode psychosis (NICE) Technology Appraisal Guidance 136 - February 2008


  • Mental Health Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • ENDOCRINE
  • 1. Recommendations for the management of diabetes in primary care (Diabetes UK - 2005)
  • 2. Complications of diabetes: Screening for retinopathy and management of foot ulcers (Effective Health Care - August 1999 Volume 5 Number 4)
  • 3. Complications of diabetes: renal disease and promotion of self-management (Effective Health Care - March 2000 Volume 6 Number 1)
  • 4. Type 2 Diabetes: National clinical guideline for management in primary and secondary care (update) (NICE) Clinical guidelines CG66 - May 2008
  • 5. Type 2 diabetes: Newer agents for blood glucose control in type 2 diabetes (NICE) Clinical guidelines CG87 - May 2009
  • 6. Guidance on the use of long-acting insulin analogues for the treatment of diabetes - insulin glargine (NICE) Technology Appraisal Guidance - No.53 - December 2002
  • 7. Guidance on the use of continuous subcutaneous insulin infusion for diabetes (NICE) Technology Appraisal Guidance - No.151 - July 2008
  • 8. Guidance on the use of patient-education models for diabetes (NICE) Technology Appraisal Guidance - No.60 - April 2003
  • 9. Human growth hormone (somatropin) in adults with growth hormone deficiency (NICE) Technology Appraisal Guidance - No.64 - August 2003
  • 10. Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy (NICE) Technology Appraisal Guidance 117 - January 2007


  • Diabetes Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • OBSTETRICS. GYNAECOLOGY & UROLOGY
  • 1. Benign prostatic hyperplasia (Effective Health Care - December 1995 Volume 2 Number 2)
  • 2. Preventing and reducing the adverse effects of unintended teenage pregnancies (Effective Health Care - February 1997 Volume 3 Number 1)
  • 3. The management of menorrhagia (Effective Health Care - 1995 Volume 1 Number 9)
  • 4. The management of gynaecological cancers (Effective Health Care - June 1999 Volume 5 Number 3)
  • 5. Guidance on the use of paclitaxel in the treatment of ovarian cancer (NICE) Technology Appraisal Guidance - No.55 - January 2003
  • 6. Guidance on the use of liquid based cytology for cervical screening (NICE Technology Appraisal Guidance 69 - October 2003
  • 7. Promoting the initiation of breastfeeding (Effective Health Care - July 2000 Volume 6 Number 2)
  • 8. Full clinical guideline on the use of electronic fetal monitoring (Published by the Royal College of Obstetricians and Gynaecologists) (Evidence Based Clinical Guideline - No.8 - May 2001)
  • 9. Induction of labour (NICE) Clinical guidelines CG70 - July 2008
  • 10. Advanced breast cancer: Diagnosis and treatment (NICE) Clinical guidelines CG81- February 2009
  • 11. Guidance on the use of trastuzumab for the treatment of advanced breast cancer (NICE) Technology Appraisal Guidance - No.34 - March 2002
  • 12. Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer (NICE) Technology Appraisal Guidance 112 - November 2006
  • 13. Routine antenatal anti-D prophylaxis for women who are rhesus D negative (NICE) Technology Appraisal Guidance 156 - August 2008
  • 14. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer (NICE) Technology Appraisal Guidance 91 - May 2005
  • 15. Urinary incontinence: The management of urinary incontinence in women (NICE) Clinical guidelines CG40 - October 2006
  • 16. Treating nocturnal enuresis in children (Effective Health Care - 2003 Volume 8 Number 2)
  • 17. Diagnosing urinary tract infection (UTI) in the under fives (Effective Health Care - 2004 Volume 8 Number 6)
  • 18. Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (NICE) Technology Appraisal Guidance - No.48 - September 2002
  • 19. Gemcitabine for the treatment of metastatic breast cancer (NICE) Technology Appraisal Guidance 116 - January 2007
  • 20. Febuxostat for the management of hyperuricaemia in people with gout (NICE) Technology Appraisal Guidance 164 - December 2008
  • 21. Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding (NICE) Technology Appraisal 78 - April 2004
  • 22. Machine perfusion systems and cold static storage of kidneys from deceased donors (NICE) Technology Appraisal Guidance 165 - January 2009
  • 23. Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma (NICE) Technology Appraisal Guidance 169 - March 2009
  • 24. Immunosuppressive therapy for renal transplantation in adults (NICE) Technology Appraisal 85 - September 2004
  • 25. Immunosuppressive therapy for renal transplantation in children and adolescents (NICE) Technology Appraisal 99 - April 2006


  • Obstetrics and Gynaecology Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • MALIGNANT DISEASE
  • 1. Guidelines for the referral of patients with breast problems (NHS Breast Screening Programme and The Cancer Research Campaign)
  • 2. Management of lung cancer (Effective Health Care - June 1998 Volume 4 Number 3)
  • 3. The management of colorectal cancer (Effective Health Care - December 1997 Volume 3 Number 6)
  • 4. The management of primary breast cancer (Effective Health Care - August 1996 Volume 2 Number 6)
  • 5. Screening for prostate cancer (Effectiveness Matters - February 1997 Volume 2 Issue 2)
  • 6. Guidelines for managing cancer pain in adults (National Council for Hospice and Specialist Palliative Care Services [3rd Ed] June 2003))
  • 7. The management of gynaecological cancers (Effective Health Care - June 1999 Volume 5 Number 3)
  • 8. Management of upper gastro-intestinal cancers (Effective Health Care - October 2000 Volume 6 Number 4)
  • 9. Advanced breast cancer: Diagnosis and treatment (NICE) Clinical guidelines CG81- February 2009
  • 10. Early and locally advanced breast cancer: Diagnosis and treatment (NICE) Clinical guidelines CG80 - February 2009
  • 11. Guidance on the use of paclitaxel in the treatment of ovarian cancer (NICE) Technology Appraisal Guidance - No.55 - January 2003
  • 12. Laparoscopic surgery for colorectal cancer (NICE) Technology Appraisal Guidance 105 - August 2006
  • 13. Informing, communicating and sharing decisions with people who have cancer (Effective Health Care - December 2000 Volume 6 Number 6)
  • 14. Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma (NICE) Technology Appraisal Guidance 121 - June 2007
  • 15. Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) (NICE) Technology Appraisal Guidance - No.23 - April 2001
  • 16. Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal) (NICE) Technology Appraisal Guidance 149 - June 2008
  • 17. Guidance on the use of gemcitabine for pancreatic cancer (NICE) Technology Appraisal Guidance - No.25 - May 2001
  • 18. The diagnosis and treatment of lung cancer: Methods, evidence and guidance (NICE) Clinical guidelines CG24 - November 2008
  • 19. Erlotinib for the treatment of non-small cell lung cancer (NICE) Technology Appraisal Guidance 162 - November 2008
  • 20. Pemetrexed for the treatment of non-small-cell lung cancer (NICE) Technology Appraisal Guidance 124 - August 2007
  • 21. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer (NICE) Technology Appraisal Guidance 91 - May 2005
  • 22. Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia (NICE) Technology Appraisal Guidance 119 - February 2007
  • 23. Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer (NICE) Technology Appraisal 93 - August 2005
  • 24. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer (NICE) Technology Appraisal 91 - May 2005
  • 25. Guidance on the use of imatinib for chronic myeloid leukaemia (NICE) Technology Appraisal 70 - October 2003
  • 26. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer (NICE) Technology Appraisal Guidance - No.61 - May 2003
  • 27. Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 145 - June 2008
  • 28. Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 172 - June 2009
  • 29. Capecitabine and oxaliplatinin the adjuvant treatment of stage III (Dukes’ C) colon cancer (NICE) Technology Appraisal 100 - April 2006
  • 30. Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer (NICE) Technology Appraisal 118 - January 2007
  • 31. Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (NICE) Technology appraisal 86 - October 2004
  • 32. Pemetrexed for the treatment of malignant pleural mesothelioma (NICE) Technology Appraisal Guidance 135 - January 2008
  • 33. Docetaxel for the treatment of hormone-refractory metastatic prostate cancer (NICE) Technology Appraisal Guidance 101 - June 2006
  • 34. Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma (NICE) Technology Appraisal Guidance 169 - March 2009
  • 35. Rituximab for the first-line treatment of chronic lymphocytic leukaemia (NICE) Technology Appraisal Guidance 174 - July 2009
  • 36. Gefitinib for the second-line treatment of locally advanced or metastatic non-small-cell lung cancer (terminated appraisal) (NICE) Technology Appraisal 175 - August 2009
  • 37. Cetuximab for the first-line treatment of metastatic colorectal cancer (NICE) Technology Appraisal Guidance 176 - August 2009
  • 38. Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (NICE) Technology Appraisal Guidance 178 - August 2009


  • Cancer Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • HAEMATOLOGY/LYMPHATIC SYSTEM
  • 1. Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia (NICE) Technology Appraisal Guidance 142 - May 2008
  • 2. Rituximab for the treatment of follicular lymphoma (NICE) Technology Appraisal Guidance 110 - September 2006
  • 3. Bortezomib monotherapy for relapsed multiple myeloma (NICE) Technology Appraisal Guidance 129 - October 2007
  • 4. Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy (NICE) Technology Appraisal Guidance 171 - June 2009
  • 5. Rituximab for aggressive non-Hodgkin’s lymphoma (NICE) Technology Appraisal 65 - September 2003

  • NUTRITION
  • 1. The prevention and treatment of obesity(Effective Health Care - April 1997 Volume 3 Number 2)
  • 2. Obesity guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children (NICE) Clinical guidelines CG43 - December 2006
  • 3. Guidance on the use of human growth hormone (somatropin) in children with growth failure (NICE) Technology Appraisal Guidance - No.42 - May 2002
  • 4. The prevention and treatment of childhood obesity (Effective Health Care - 2002 Volume 7 Number 6)
  • 5. Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia (NICE) Technology Appraisal Guidance 132 - November 2007

  • SURGERY
  • 1. Surgical site infection: Prevention and treatment of surgical site infection (NICE) Clinical guidelines CG74 - October 2008
  • 2. Pre-hospital initiation of fluid replacement therapy in trauma (NICE) Technology appraisal 74 - January 2004


  • Surgery Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • MUSCULOSKELETAL & JOINTS
  • 1. Primary care guide on the prevention and treatment of osteoporosis (Department of Health & Royal College of Physicians - June 1998)
  • 2. Upper limb disorders: Occupational aspects of management (Royal College of Physicians - June 2009)
  • 3. Rheumatoid arthritis: National clinical guideline for management and treatment in adults (Royal College of Physicians - February 2009)
  • 4. Osteoarthritis: National clinical guideline for care and management in adults (Royal College of Physicians - February 2008)
  • 5. Glucocorticoid-induced osteoporosis: Guidelines for prevention and treatment (Royal College of Physicians - December 2002)
  • 6. Total hip replacement (Effective Health Care - October 1996 Volume 2 Number 7)
  • 7. Clinical guidelines for the management of acute low back pain (Royal College of General Practitioners)
  • 8. Guidance on the selection of prostheses for primary total hip replacement (NICE) Technology Appraisal Guidance - No.2 - April 2000
  • 9. Guidance on the use of metal on metal hip resurfacing arthroplasty (NICE) Technology Appraisal Guidance - No.44 - June 2002
  • 10. The use of autologous chondrocyte implantation for the treatment of cartilage defects in knee joints (NICE) Technology Appraisal 89 - May 2005
  • 11. Acute and chronic low back pain (Effective Health Care - November 2000 Volume 6 Number 5)
  • 12. Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis (NICE) Technology Appraisal Guidance - No.35 - March 2002
  • 13. Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis (Partially replaced by TA130) (NICE) Technology Appraisal Guidance - No.36 - March 2002
  • 14. Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis (NICE) Technology Appraisal Guidance 130 - October 2007
  • 15. Abatacept for the treatment of rheumatoid arthritis (NICE) Technology Appraisal Guidance 141 - April 2008
  • 16. Rituximab for the treatment of rheumatoid arthritis (NICE) Technology Appraisal Guidance 126 - August 2007
  • 17. Adalimumab, etanercept and infliximab for ankylosing spondylitis (NICE) Technology Appraisal Guidance 143 - May 2008
  • 18. Osteoarthritis: National clinical guideline for care and management in adults (NICE) Clinical guidelines CG59 - February 2008
  • 19. Rheumatoid arthritis: National clinical guideline for care and management in adults (NICE) Clinical guidelines CG79 - February 2009
  • 20. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (NICE) Technology Appraisal Guidance 160 - October 2008
  • 21. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (NICE) Technology Appraisal Guidance 161 - October 2008
  • 22. Adalimumab for the treatment of psoriatic arthritis (NICE) Technology Appraisal Guidance 125 - August 2007
  • 23. Etanercept and infliximab for the treatment of adults with psoriatic arthritis (NICE) Technology Appraisal Guidance 104 - July 2006


  • Orthopaedics Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • EYE, EAR NOSE AND THROAT
  • 1. Management of cataract (Effective Health Care - February 1996 Volume 2 Number 3)
  • 2. The treatment of persistent glue ear in children (Effective Health Care - November 1992 Number 4)
  • 3. Cochlear implants for children and adults with severe to profound deafness (NICE) Technology Appraisal Guidance 166 - January 2009
  • 4. Complications of diabetes: Screening for retinopathy and management of foot ulcers (Effective Health Care - August 1999 Volume 5 Number 4)
  • 5. Pre-school hearing, speech, language and vision screening (Effective Health Care - April 1998 Volume 4 Number 2)
  • 6. Royal College of Speech & Language Therapists Clinical Guidelines (Royal College of Speech and Language Therapists - 2005)
  • 7. Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 145 - June 2008
  • 8. Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 172 - June 2009
  • 9. Guidance on the use of photodynamic therapy for age-related macular degeneration (NICE) Technology Appraisal 68 - September 2003
  • 10. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration (NICE) Technology Appraisal Guidance 155 - August 2008
  • 11. Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome (NICE) Technology Appraisal Guidance 139 - March 2008


  • ENT Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • DENTISTRY, ORAL SURGERY
  • 1. Guidance on the extraction of wisdom teeth (NICE) Technology Appraisal Guidance - No.1 - March 2000
  • 2. Dental restoration: what type of filling? (Effective Health Care - April 1999 Volume 5 Number 2)
  • 3. HealOzone for the treatment of tooth decay (occlusal pit and fissure caries and root caries) (NICE) Technology Appraisal 92 - July 2005


  • Dentistry Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

  • SKIN
  • 1. Compression therapy for venous leg ulcers (Effective Health Care - August 1997 Volume 3 Number 4)
  • 2. The prevention and treatment of pressure sores (Effective Health Care - October 1995 Volume 2 Number 1)
  • 3. Treating head lice and scabies (Effectiveness Matters - June 1999 Volume 4 Issue 1)
  • 4. The management of pressure ulcers in primary and secondary care: A clinical practice guideline (NICE) Clinical guidelines CG29 - September 2005
  • 5. Frequency of application of topical corticosteroids for atopic eczema (NICE) Technology Appraisal 81 - August 2004
  • 6. Tacrolimus and pimecrolimus for atopic eczema (NICE) Technology Appraisal 82 - August 2004
  • 7. Adalimumab for the treatment of adults with psoriasis (NICE) Technology Appraisal Guidance 146 - June 2008
  • 8. Etanercept and efalizumab for the treatment of adults with psoriasis (NICE) Technology Appraisal Guidance 103 - July 2006
  • 9. Infliximab for the treatment of adults with psoriasis (NICE) Technology Appraisal Guidance 134 - January 2008
  • 10. Alitretinoin for the treatment of severe chronic hand eczema (NICE) Technology Appraisal Guidance 177 - August 2009

  • IMMUNISATION AND VACCINATION
  • 1. Summary of flu immunisation policy (Department of Health - 30 April 2009)
  • 2. Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza (NICE) Technology Appraisal Guidance 158 - September 2008
  • 3. Amantadine, oseltamivir and zanamivir for the treatment of influenza (NICE) Technology Appraisal Guidance 168 - February 2009

  • GENERAL
  • 1. Implementing clinical practice guidelines (Effective Health Care - December 1994 Number 8)
  • 2. Hospital volume and health care outcomes, costs and patient access (Effective Health Care - December 1996 Volume 2 Number 8)
  • 3. Preventing unintentional injuries in children and young adolescents (Effective Health Care - June 1996 Volume 2 Number 5)
  • 4. Smoking cessation: What the health service can do (Effectiveness Matters - March 1998 Volume 3 Number 1)
  • 5. Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities (NICE) Public Health Guidance 10 - February 2008
  • 6. Varenicline for smoking cessation (NICE) Technology Appraisal Guidance 123 - July 2007
  • 7. Making the best use of a department of clinical radiology (The Royal College of Radiologists: (6th edition) 2007)
  • 8. Deliberate self-harm (Effective Health Care - December 1998 Volume 4 Number 6)
  • 9. Getting evidence into practice (Effective Health Care - February 1999 Volume 5 Number 1)
  • 10. Preventing falls and subsequent injury in older people (Effective Health Care - April 1996 Volume 2 Number 4)
  • 11. Preventing the uptake of smoking in young people (Effective Health Care - October 1999 Volume 5 Number 5)
  • 12. Acupuncture (Effective Health Care - November 2001 Volume 7 Number 2)
  • 13. Homeopathy (Effective Health Care - 2002 Volume 7 Number 3)
  • 14. Guidance on the use of ultrasound locating devices for placing central venous catheters (NICE) Technology Appraisal Guidance - No.49 - September 2002


  • Child Health Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))
  • Sexually Transmitted Diseases Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))
  • Other Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))



  • © Michael Rowe 1997

    Classification Scheme reproduced by kind permission of the National Library of Medicine

    return